For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of Vyndamax and the formulated version represents a significant breakthrough . These novel therapies stabilize the transthyretin protein, preventing its damaging build-up and reducing the severity of the disease . People are now experiencing b… Read More